Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
10.77
-0.21 (-1.91%)
Dec 22, 2025, 1:47 PM EST - Market open
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $386.23 million as of December 22, 2025. Its market cap has decreased by -45.35% in one year.
Market Cap
386.23M
Enterprise Value
119.32M
1-Year Change
-45.35%
Ranking
Category
Stock Price
$10.77
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has increased from $251.01M to $386.23M, an increase of 53.87%. That is a compound annual growth rate of 10.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 393.76M | -35.68% |
| Dec 31, 2024 | 612.16M | 21.70% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
| Oct 29, 2021 | 251.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 956.27B |
| Johnson & Johnson | 495.74B |
| AbbVie | 399.99B |
| UnitedHealth Group | 296.76B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 254.11B |
| Abbott Laboratories | 219.79B |